In Vitro Models for Studying Angiogenesis

We use cookies to ensure the best experience on our website.
View Cookie Policy
_self
Accept Cookie Policy
Change My Settings
ESSENTIAL COOKIES
Required for the site to function.
PREFERENCE AND ANALYTICS COOKIES
Augment your site experience.
SOCIAL AND MARKETING COOKIES
Lets Corning work with partners to enable social features and marketing messages.
ALWAYS ON
ON
OFF

最好使用最新版的 Google Chrome 和 Mozilla Firefox 查看该页面。

Close[x]
Events
CLS
In Vitro Models for Studying Angiogenesis
In Vitro Models for Studying Angiogenesis
2014年10月30日 12点00分
Online
Time: 12:00 - 1:00 pm

Angiogenesis is the process by which a new blood supply is established from pre-existing blood vessels. It is initiated by degradation of vessel basement membrane, endothelial cell proliferation, invasion, and directional migration towards chemoattractants, tube formation, and finally the establishment of a new vasculature.

Register now to learn how Corning products can be used to help you more accurately replicate and investigate the specific stages of angiogenesis through standardized and quantitative in vitro cell-based assays.

  • HUVEC-2 Endothelial Cells - Widely studied endothelial cells that have been pre-screened for responsiveness to VEGF, a prototypic stimulator of angiogenesis
  • ECMs and Chemoattractants - ECMs, like Corning® Matrigel® Matrix, provide key pro-angiogenic chemoattractants for optimal EC propagation, attachment, differentiation, and other key functions as well as provide support and structure for more in vivo-like tumor angiogenesis modeling
  • Endothelial Cell Invasion and Migration Assays - Corning FluoroBlok™ microporous permeable supports coated with our unique extracellular matrix proteins allow quantitation of endothelial cell migration and invasion, automated screening and reproducible quantification of prospective pro- and anti-angiogenic compounds
  • Endothelial Cell Tube Formation Assay - A rapid assay system, this approach is relatively easy to set up, is quantifiable and allows for direct screening of angiogenic compounds for their effects on endothelial cell tube formation

About our Presenter
Paula Flaherty is a Technology Manager at Corning Life Sciences. Her team develops strategy and products focused on the modulation of in vitro cell behavior using extracellular matrix, media, vessel design, and growth factors. Prior to joining Corning Life Sciences, Paula studied retinal degeneration at the Berman-Gund Laboratory, Harvard Medical School in Boston, MA. She received her bachelor’s degree in Microbiology from the State University of New York and is an In Vitro Cell Biology Fellow, W. Alton Jones Cell Science Center in Lake Placid, NY.

Note: All Corning webinar presentations are available on our website on demand for viewing at your convenience.

Read More
分享